-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

CME Eligible Sessions

Friday, December 6, 2024

top

7:00 AM-10:00 AM


Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia – What Clinicians Want to Know  
Friday Satellite Symposia


Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia - What Clinicians Want to Know  
Friday Satellite Symposia


An Interactive Case-based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates  
Friday Satellite Symposia


Bridging Gaps in Multiple Myeloma Care: A Community Oncologist's Guide to Navigating the Evolving Treatment Landscape  
Friday Satellite Symposia


Championing the Care of Relapsed/Refractory Multiple Myeloma: Practical Strategies to Integrate Bispecific Antibodies  
Friday Satellite Symposia


Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience + Innovation for More Personalized Disease Control  
Friday Satellite Symposia


MDS 2024: Let’s Overcome the Challenges  
Friday Satellite Symposia


Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease  
Friday Satellite Symposia

9:00 AM-12:00 PM


Training Program Directors Workshop  
Special-Interest Sessions

11:00 AM-2:00 PM


Addressing Current Questions and Controversies in the Management of Myelofibrosis - What Clinicians Want to Know  
Friday Satellite Symposia


Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma - What Clinicians Want to Know  
Friday Satellite Symposia


A Game Changer for Follicular Lymphoma: Mastering Use of Precision Therapies as Part of a Chemo-free Treatment Paradigm  
Friday Satellite Symposia


A New Era for Hemophilia Treatment: Common Goals, Unique Perspectives  
Friday Satellite Symposia


Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors  
Friday Satellite Symposia


A Violent Graft in a Vulnerable Host: The Future of aGVHD Management  
Friday Satellite Symposia


Collaborating for Optimal Immune Thrombocytopenia Care: Uniting Disease, Treatment, and Patient-Centered Considerations  
Friday Satellite Symposia


Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-based Platforms  
Friday Satellite Symposia


Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis  
Friday Satellite Symposia


Evolving Treatment Paradigms for Patients with Hemoglobinopathies  
Friday Satellite Symposia


From Barriers to Breakthroughs in Multiple Myeloma: How Trials Compare to the Real-World Management of Patients in Your Practice  
Friday Satellite Symposia


Guiding Our Patient's Path: Managing First Relapse in Diffuse Large B-Cell Lymphoma Outside of CAR Ts  
Friday Satellite Symposia


Maximizing Touchpoints to Empower Impactful Patient-Centered Care for Paroxysmal Nocturnal Hemoglobinuria  
Friday Satellite Symposia


Medical Crossfire®: Bridging Evidence to Practice in AML... Updates on FLT3, IDH1/2, Maintenance, Combos, and Clinical Trials  
Friday Satellite Symposia


Next Up: Conversations On Optimizing CD38 Antibody-Based Triplet Regimens For Early-Relapse Multiple Myeloma  
Friday Satellite Symposia


Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL  
Friday Satellite Symposia

3:00 PM-6:00 PM


Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia - What Clinicians Want to Know  
Friday Satellite Symposia


Addressing Current Questions and Controversies in the Management of Multiple Myeloma - What Clinicians Want to Know  
Friday Satellite Symposia


A Step-By-Step Approach to CAR T-cell Therapy for RRMM: From Bridging to Sequencing and Adverse Event Management  
Friday Satellite Symposia


Bispecific Antibodies: A Playbook for Relapsed/Refractory Follicular Lymphoma  
Friday Satellite Symposia


Cases and Conversations™: The Rationale for Utilizing Non-Factor Replacement Therapies in Hemophilia Care  
Friday Satellite Symposia


Clinical assessment of gene therapies for hemophilia A and hemophilia B: Key takeaways for your practice  
Friday Satellite Symposia


Complex Cases in the Community Clinic: Managing Diverse Hematologic Malignancies  
Friday Satellite Symposia


Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Ever-Evolving Treatment of MF, PV, and ET  
Friday Satellite Symposia


Medical Crossfire®: New Horizons in Acute Lymphoblastic Leukemia—How The Experts Apply New Evidence from AYA to Adult Scenarios  
Friday Satellite Symposia


Sharing Best Practices from the ALL/LBL Clinic: Navigating Patient-Centered Care with Asparaginase Therapies  
Friday Satellite Symposia


Unleashing Emerging Therapies to Modify Myelofibrosis Pathogenesis: Shifting the Treatment Paradigm to Target Deeper Clinical and Molecular Responses  
Friday Satellite Symposia

7:00 PM-10:00 PM


Accelerating the Adoption of the Latest Evidence on Sequencing Therapies for Multiple Myeloma Across Practice Settings  
Friday Satellite Symposia


How We Do It®: New Combinations Reshaping Treatment Decision-Making in Newly Diagnosed Multiple Myeloma  
Friday Satellite Symposia


Show Me the Data™: How Do We Navigate the Latest Evidence on Novel Therapies and Trials Across GvHD Prophylaxis, Acute, and Chronic Care?  
Friday Satellite Symposia


Show Me the Data™: Pushing CAR T’s Forward Across Lymphoid Malignancies... Accelerating Access in the Community and Treatment Strategies for the Road Ahead  
Friday Satellite Symposia

Saturday, December 7, 2024

top

8:00 AM-9:00 AM


How I Treat: Acute Lymphoblastic Leukemia Incorporating New Treatment Options (ticketed session for in-person participants)  
How I Treat


How I Treat: Challenges and Management of Cancer Associated Thrombosis (ticketed session for in-person participants)  
How I Treat


How I Treat: Follicular Lymphoma Incorporating New Treatment Options (ticketed session for in-person participants)  
How I Treat


How I Treat: Gene Therapy in Sickle Cell Disease (ticketed session for in-person participants)  
How I Treat


How I Treat: Options for Long-Term Management of Hemophilia (ticketed session for in-person participants)  
How I Treat


Meet the Scientist: CAR-T and CAR-NK in Therapy of Hematologic Malignancies (Ticketed session for in-person participants)  
Meet the Scientist


Meet the Scientist: Epigenetic Regulation in Bone Marrow Failure (Ticketed session for in-person participants)  
Meet the Scientist


Meet the Scientist: Production of Functional Hematopoietic Stem Cells from Pluripotent Cells (Ticketed session for in-person participants)  
Meet the Scientist


Meet the Scientist: Therapy-Related Myeloid Neoplasms (Ticketed session for in-person participants)  
Meet the Scientist


Meet the Scientist: Transferrin Receptor Physiology and Iron Metabolism (Ticketed session for in-person participants)  
Meet the Scientist

9:30 AM-10:45 AM


A Little Less Conversation, a Little More Action: An Outcome Equity Roadmap for Children and AYAs With Leukemia and Lymphoma  
Education Program


ALPS, CVID, and LGL: When Autoimmune Cytopenias Are a Marker of Underlying Immune Disease  
Education Program


AML M&Ms: How to Integrate Mutations and MRD Data  
Education Program


Ineffective Erythropoiesis: Insights Into Molecular Mechanisms and Disease Pathophysiology  
Scientific Program


Moving the Needle in Hodgkin Lymphoma  
Education Program


Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation  
Education Program


Optimizing Non-Curative Therapies for Sickle Cell Disease  
Education Program


Proteo-Genomics to Better Study Multiple Myeloma Biology and Evolution  
Scientific Program


The Expanding Landscape of Treatment for ITP  
Education Program


Understanding the Impact of Donor and Recipient Metabolic Variability on Blood Transfusion Outcomes  
Scientific Program

9:30 AM-11:00 AM


ASH ISTH Clinical Practice Guidelines on Treatment of Venous Thromboembolism (VTE) in Pediatric Patients  
Special-Interest Sessions

12:30 PM-1:30 PM


2024 Ham-Wasserman Lecture  
Marquee Sessions

2:00 PM-3:15 PM


Beyond TTP: "Atypical" TMAs for the Hematologist  
Education Program


Chasing Zebras: Navigating Rare Myeloid Neoplasms  
Education Program


Hematologic Challenges at the End-of-Life  
Education Program


Hematologic Management of the Patient with Heavy Menstrual Bleeding  
Education Program


Host Factors Driving Anti-Leukemia Immunotherapy Outcomes  
Scientific Program


Integrating New Therapies into the Management of Classical Heme Disorders  
Education Program


Ironing Out the Wrinkles: Managing Iron Overload in Different Clinical Scenarios  
Education Program


Newly Diagnosed Multiple Myeloma: Many Choices and More Questions  
Education Program

2:00 PM-3:30 PM


Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities  
Special-Interest Sessions

4:00 PM-5:15 PM


Handling Bad News: How to Best Manage TP53 Myeloid Disease  
Education Program


HIT-and-Run: Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia  
Education Program


Interface of Complement and Coagulation  
Scientific Symposia


Monoclonal Gammopathies: When the Clone Is More Than a Positive Laboratory Finding  
Education Program

4:00 PM-5:30 PM


Artificial Intelligence in Hematology: From Generative AI to Ethics and Applications  
Special-Interest Sessions

4:00 PM-5:35 PM


JOINT SESSION: Molecular Characterization of Lymphomas in Children, Adolescents, and Young Adults  
Scientific Program


JOINT SESSION: Newly Described Functions in the Vascular Space  
Scientific Program


JOINT SESSION: The Fuel & Physiology of Regeneration  
Scientific Program

Sunday, December 8, 2024

top

7:30 AM-9:30 AM


Medical Educators Symposium  
Special-Interest Sessions

8:00 AM-9:00 AM


How I Treat: Acute Myeloid Leukemia with Targetable Mutations (ticketed session for in-person participants)  
How I Treat


How I Treat: Adult Outpatient CAR T Therapy (ticketed session for in-person participants)  
How I Treat


How I Treat: A Personal Journey with Castleman Disease (ticketed session for in-person participants)  
How I Treat


How I Treat: Newly Diagnosed Multiple Myeloma (ticketed session for in-person participants)  
How I Treat


How I Treat: Sickle Cell Disease in Africa (ticketed session for in-person participants)  
How I Treat


Meet the Scientist: Mechanisms of Drug Resistance in Acute Myeloid Leukemia (Ticketed session for in-person participants)  
Meet the Scientist


Meet the Scientist: Microenvironment Regulation of Hematopoietic Stem Cells (Ticketed session for in-person participants)  
Meet the Scientist


Meet the Scientist: Pluripotent Stem Cell-Based Modeling of Hematologic Malignancies (Ticketed session for in-person participants)  
Meet the Scientist


Meet the Scientist: What Does the Future Hold for Management of Hemophilia? (Ticketed session for in-person participants)  
Meet the Scientist

9:30 AM-10:45 AM


Interrogating the Impact of the Intestinal Microbiome on Transplant and Cellular Therapies  
Scientific Symposia


Metabolic Deregulation in Hematopoietic Neoplasia: Tumor, The Environment, and Therapies.  
Scientific Program


MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy  
Education Program


Overcoming Post-transplant Relapse: How to Win the Battle Royale  
Education Program

9:30 AM-11:00 AM


ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults  
Special-Interest Sessions


Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology  
Special-Interest Sessions


Sickle Cell Disease Centers Session  
Special-Interest Sessions

9:30 AM-11:05 AM


JOINT SESSION: Emerging Therapeutic Strategies Targeting Epigenetic, Transcriptomic, and Metabolic Mechanisms  
Scientific Program


JOINT SESSION: Therapeutic Gene Editing of Stem Cells in Classical and Malignant Hematology  
Scientific Program

11:15 AM-12:30 PM


ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly  
Special-Interest Sessions

12:30 PM-1:30 PM


ASH-EHA Joint Symposium  
Marquee Sessions

4:30 PM-5:45 PM


Biology Underlying Disparities in Lymphoid Malignancies  
Spotlight Sessions


Challenges in Cancer-Associated Thrombosis  
Education Program


Curative Therapies for Sickle Cell Disease: Option for Some but Not Quite All  
Spotlight Sessions


Follicular Lymphoma: Playing the Long Game  
Education Program


Inflammation as a Regulator of Hematopoietic Homeostasis in Disease and Clonal Selection  
Spotlight Sessions


Newly Discovered Functions of Megakaryocytes and Platelets  
Scientific Symposia


The Clone Wars: Myeloid Neoplasia Risk in Clonal Hematopoiesis  
Spotlight Sessions

4:30 PM-6:00 PM


ASH Clinical Practice Guidelines on Amyloidosis  
Special-Interest Sessions


Symposium for Mid-Career Hematologists  
Special-Interest Sessions

4:30 PM-6:30 PM


Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management  
Special-Interest Sessions

Monday, December 9, 2024

top

9:00 AM-10:00 AM


E. Donnall Thomas Lecture and Prize  
Marquee Sessions

10:30 AM-11:45 AM


Anticoagulation SOS: Navigating Monitoring Conundrums  
Education Program


A Shifting Landscape: Treatment of MCL  
Education Program


Challenges and Opportunities of Sickle Cell Care in Africa  
Education Program


It's a Different World: CLL 2024  
Education Program


Leveraging Single Cell Multi-Omics to Understand Mechanisms of Myeloid Lineage Expansion in Aging and Disease.  
Scientific Program


Making a Match: Optimal Donor HLA and Beyond  
Spotlight Sessions


Smoldering Myeloma: A Case for Early Intervention?  
Spotlight Sessions

10:30 AM-12:00 PM


ASH-FDA Joint Symposium I: Accelerating Drug Development for Hematologic Malignancies  
Special-Interest Sessions


Clinical Care and Research Implications Following Voxelotor Withdrawal  
Special-Interest Sessions


Early Faculty Career Development Session  
Special-Interest Sessions

1:30 PM-2:30 PM


Ernest Beutler Lecture and Prize  
Marquee Sessions

2:45 PM-4:00 PM


Adult ALL Advancements: Optimizing Cure in 2024  
Education Program


Fulfilling the Promise: Pluripotent Stem Cells as Models for Human Blood Development and Disease  
Spotlight Sessions


Gene Therapy and Hemophilia A: What Is the Future of Curative Therapy in the Age of Emicizumab?  
Spotlight Sessions


Iron at the Crossroads Between Erythropoiesis and Megakaryopoiesis  
Spotlight Sessions


Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?  
Education Program

2:45 PM-4:15 PM


ASH Quality Improvement Champions  
Special-Interest Sessions

4:30 PM-5:45 PM


Addressing Unmet Needs in T Cell Lymphomas  
Education Program


Adult CAR-T Outcomes: Beyond the Acronyms (OS, PFS, CRS, ICANS)  
Education Program


Crosstalk Between Iron Homeostasis and Metabolism  
Scientific Program


Placing the Brakes on Accelerated Aging  
Scientific Symposia


Vascular Anomalies, Vascular Malformations, and the Role of the Hematologist  
Education Program

4:30 PM-6:00 PM


ASH-FDA Joint Symposium II: Challenges and Innovations in Rare Diseases in Non-Malignant Hematology  
Special-Interest Sessions


Special Symposium on the Basic Science of Hemostasis and Thrombosis  
Scientific Symposia

Tuesday, December 10, 2024

top

9:45 AM-11:15 AM


2024 Presidential Symposium  
Marquee Sessions